SIGA TECHNOLOGIES INC
SIGANext catalyst
Smallpox and Mpox Vaccine
Smallpox
Get an email about SIGA's next catalysts
Track SIGA TECHNOLOGIES (SIGA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (earnings).See the timeline
2 upcoming, 0 past
SIGA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: amc
Tecovirimat Phase 2 Est. Readout
Estimated primary completion for Tecovirimat trial (NCT04957485) in Smallpox. Topline data typically follows completion by weeks to months.
SourceMarket Overview
Stock performance and key metrics
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.
Websitetecovirimat
Smallpox
TPOXX
Smallpox
Smallpox and Mpox Vaccine
Smallpox
ST-246
Orthopoxviral Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
tecovirimat | Phase 3 | Smallpox | - | - |
TPOXX | Phase 3 | Smallpox | - | - |
Smallpox and Mpox Vaccine | Phase 2 | Smallpox | - | - |
ST-246 | Phase 2 | Orthopoxviral Disease | - | - |
Frequently asked questions
What is in SIGA TECHNOLOGIES INC's drug pipeline?→
CatalystAlert tracks 4 drug candidates in SIGA TECHNOLOGIES INC's (SIGA) pipeline across Phase 3, Phase 2. Its lead program is tecovirimat (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is SIGA TECHNOLOGIES INC's next FDA catalyst?→
SIGA TECHNOLOGIES INC's (SIGA) next tracked catalyst is a Phase 2 readout expected January 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track SIGA biotech catalysts?→
Add SIGA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow SIGA TECHNOLOGIES INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.